These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation]. Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498 [No Abstract] [Full Text] [Related]
9. [Penicillamine therapy of chronic liver diseases]. Wildhirt E MMW Munch Med Wochenschr; 1974 Feb; 116(5):217-20. PubMed ID: 4205098 [No Abstract] [Full Text] [Related]
10. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study]. Gasbarrini G; Bernardi M Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448 [No Abstract] [Full Text] [Related]
11. [Thiomesterone and liver function]. Pickert H Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699 [No Abstract] [Full Text] [Related]
12. [Clinical study on the treatment of liver disease with glucocorticoids]. Oda T; Suzuki H; Naito C; Yamanada M; Oka H Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229 [No Abstract] [Full Text] [Related]
13. [Long-term therapy of liver diseases]. Markoff N Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921 [No Abstract] [Full Text] [Related]
14. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp]. Busse K; Otremba P Soins; 1970; 15(7):2608-13. PubMed ID: 4918343 [No Abstract] [Full Text] [Related]
15. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates. Glogner P; Massarrat S; Henrichs HR Acta Hepatosplenol; 1971; 18(5):394-7. PubMed ID: 5112056 [No Abstract] [Full Text] [Related]
16. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research]. Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140 [No Abstract] [Full Text] [Related]
17. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)]. Reutter FW; Haase W Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576 [No Abstract] [Full Text] [Related]
19. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions]. Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451 [No Abstract] [Full Text] [Related]
20. [Clinico-statistical study of the therapeutic activity of coenzyme A in various hepatopathies]. Ruberti A; Tobaldin G; Montanari MG; Castellani P Clin Ter; 1971 May; 57(4):309-42. PubMed ID: 5110947 [No Abstract] [Full Text] [Related] [Next] [New Search]